Evidence map›Paper›PMID 32194717›Full record

ArticleOncology letters2020

Analysis of the methylation of CpG islands in the

Hiroshi Maekawa, Tomoaki Ito, Hajime Orita, Tomoyuki Kushida, Mutsumi Sakurada, Koichi Sato, Alicia Hulbert, Malcolm V Brock

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. A BIRC5Cancer informatics · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hiroshi MaekawaDepartment of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Izunokuni, Shizuoka 410-2295, Japan.
Tomoaki ItoDepartment of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Izunokuni, Shizuoka 410-2295, Japan.
Hajime OritaDepartment of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Izunokuni, Shizuoka 410-2295, Japan.
Tomoyuki KushidaDepartment of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Izunokuni, Shizuoka 410-2295, Japan.
Mutsumi SakuradaDepartment of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Izunokuni, Shizuoka 410-2295, Japan.
Koichi SatoDepartment of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Izunokuni, Shizuoka 410-2295, Japan.
Alicia HulbertDepartment of Surgery, The Sidney Kimmel Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA.
Malcolm V BrockDepartment of Surgery, The Sidney Kimmel Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA.
Juntendo University Shizuoka Hospital · JPJohns Hopkins University · USSidney Kimmel Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No difference in the gene methylation status of tumor-suppression genes between pancreatic cancer tissues and adjacent non-cancer tissues is observed. The present study investigated whether the promoter CpG islands of the cysteine dioxygenase 1 (

Indexed as

CDO1CHFRmethylationpancreatic cancerpromoterTAC1

Identifiers

PMID32194717
PMCPMC7039134
OpenAlexW3002766432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.